May 23, 2024· Comment from Association for Accessible Medicines (AAM)· FDA-2002-D-0176-0014
FDA, Please find attached comments from The Association for Accessible Medicines (AAM) regarding Docket No. FDA–2002–D–0176, "Handling and Retention of Bioavailability and Bioequivalence Testing Samples; Guidance for Industry" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, Association for Accessible Medicines